Published online Oct 15, 2002. doi: 10.3748/wjg.v8.i5.928
Revised: August 6, 2002
Accepted: August 15, 2002
Published online: October 15, 2002
AIM: To provide scientific evidence for prevention and controlling of blastocystosis, the infection of Blastocystis homonis and to study its clinical significance in Huainan City, Anhui Province, China.
METHODS: Blastocystis homonis in fresh stools taken from 100 infants, 100 pupils, 100 middle school students and 403 patients with diarrhea was smeared and detected with method of iodine staining and hematoxylin staining. After preliminary direct microscopy, the shape and size of Blastocystis homonis were observed with high power lens. The cellular immune function of the patients with blastocystosis was detected with biotin-streptavidin (BSA).
RESULTS: The positive rates of Blastocystis homonis in fresh stools taken from the infants, pupils, middle school students and the patients with diarrhea, were 1.0% (1/100), 1.0% (1/100), 0% (0/100) and 5.96% (24/403) respectively. Furthermore, the positive rates of Blastocystis homonis in the stool samples taken from the patients with mild diarrhea, intermediate diarrhea, severe diarrhea and obstinate diarrhea were 6.03% (14/232), 2.25% (2/89), 0% (0/17) and 12.31% (8/65) respectively. The positive rates of Blastocystis homonis in fresh stools of male and female patients with diarrhea were 7.52% (17/226) and 3.95% (7/177) respectively, and those of patients in urban and rural areas were 4.56% (11/241) and 8.02% (13/162) respectively. There was no significant difference between them (P > 0.05). The positive rates of CD3+, CD4+, CD8+ in serum of Blastocystis homonis-positive and-negative individuals were 0.64 ± 0.06, 0.44 ± 0.06, 0.28 ± 0.04 and 0.60 ± 0.05, 0.40 ± 0.05 and 0.30 ± 0.05 respectively, and the ratio of CD4+/CD8+ of the two groups were 1.53 ± 0.34 and 1.27 ± 0.22. There was significant difference between the two groups (P < 0.05, P < 0.01).
CONCLUSION: The prevalence of Blastocystis hominis as an enteric pathogen in human seems not to be associated with gender and living environment, and that Blastocystis hominis is more common in stool samples of the patients with diarrhea, especially with chronic diarrhea or obstinate diarrhea. When patients with diarrhea infected by Blastocystis hominis, their cellular immune function decreases, which make it more difficult to be cured.
-
Citation: Wang KX, Li CP, Wang J, Cui YB. Epidemiological survey of
Blastocystis hominis in Huainan City, Anhui Province, China. World J Gastroenterol 2002; 8(5): 928-932 - URL: https://www.wjgnet.com/1007-9327/full/v8/i5/928.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i5.928
Blastocystis homonis (B.h) is increasingly recognized to be a cause of human enteric disease. Its presence has been reported in a wide variety of intestinal disorders resembling irritable bowel syndrome (IBS) such as bloating, flatulence, mild to moderate diarrhea, abdominal pain, and nausea[1-35]. The geographic distribution of Blastocystis homonis appears to be global, with infections common in tropical, subtropical and developing countries[36-40]. In general, studies from developed countries report approximately a 1.5% to 10% overall prevalence of Blastocystis homonis[41-45]. However, few reports of the prevalence and the importance of the protozoan Blastocystis homonis as an intestinal pathogen in China have been found. In order to explore the epidemiological characteristics and clinical significance of blastocystosis in population of the city of Huainan, a prospective study was carried out from July to August in 2001.
The study was performed in the following groups of the population in Huainan: in a healthy population (n = 300, normal group), including infants in day-care centers (n = 100), pupils (n = 100) and middle school students (n = 100), and in outpatients with diarrhea (n = 403, male 226 and female 177, aged from 6 to 52 years). In addition, we paid more attention to the patients with intractable diarrhea.
A questionnaire, administered by a nurse, was used to collect detailed information of each subject investigated. Information was collected by means of in-person, telephone and interview, including age, gender, history of present illness, anamnesis, symptomatology (i.e. fever, upper respiratory tract infection, nausea, diarrhea, abdominal cramps, bloating, steatorrhea), date of symptom onset, duration of symptoms, personal health habits, and living environmental condition and the date of stool sample collected.
Stool examination All individuals were asked to provide one stool sample in disposable stool boxes for analysis. Samples were sent to the Department of Etiology and Immunology, School of Medicine, Anhui University of Science & Technology in Huainan for Blastocystis homonis. Then the sample was smeared to semitransparent feces membrane on the surface of sheet slides. After these smears were left to dry naturally and fixed with methanol, iodine solution and hematoxylin staining were made, and examination under microscope was carried out. The shape and size of Blastocystis homonis were observed.
Detection of T lymphocyte subsets To investigate possible changes of cellular immune function in Blastocystis homonis-infected individuals, the level of CD3+, CD4+, CD8+ and CD4+/CD8+ in peripheral blood of Blastocystis homonis-positive individuals were tested with biotin-streptavidin (BSA) method. Firstly, peripheral venous blood of subjects was withdrawn, anticoagulated with heparin, and diluted with fluid free of Ca2+, Mg2+. Secondly, peripheral blood mononuclear cells were separated with lymphocytes separating medium, cleaned, and the number of cells was adjusted to (1-3) × 109/L of which 10 μL was taken and smeared in an acid-proof varnish circle on the surface of the slides. When it dried naturally, McAb of anti-CD3+, anti-CD4+ and anti-CD8+ and sheep anti-guineapig IgG, SA- HRP were added into the circle. After development with DAB, the slides were observed under microscope. Only brown cytomembrane staining was regarded as positive, otherwise, as negative specimen. A total of 200 cells were counted, and the positive percentage of cells were analyzed respectively.
The positive rates were expressed as percentage, and the statistical analysis was carried out by using χ² and t-test. A probability value of less than 0.05 was considered statistically significant.
Of the 703 stool samples examined, 3.70% (26/703) were found to be positive for Blastocystis hominis. Furthermore, the positive rate of Blastocystis hominis in 300 stools of healthy people was 0.67% (2/300); and those of infants, pupils and middle school students were 1.00% (1/100), 0 (0/100) and 1.00% (1/100) respectively. In addition, The positive rates of Blastocystis hominis in the stools taken from the outpatients with mild diarrhea, intermediate diarrhea, severe diarrhea and obstinate diarrhea were 6.03% (14/232), 2.25% (2/89), 0% (0/17) and 12.31% (8/65) respectively. There was significant difference in the positive rates between each type of patients (P < 0.05). The detailed results are showed in Table 1.
Of the 403 outpatients, the positive rates of Blastocystis hominis in male and female patients were 7.52% (17/226) and 3.95% (7/177) respectively. Statistics found no significant difference in positive rate between male and female.
The positive rates of Blastocystis hominis in stools taken from patients with diarrhea living in urban and in rural areas were 7.52% (17/226) and 3.95% (7/177) respectively. There was no significant difference between the two groups (P > 0.05).
The positive rate of Blastocystis hominis in stools of healthy people was 0.67% (2/300), while that of diarrheic patients was 5.96% (24/403). Among the patients with diarrhea, the positive rates of Blastocystis hominis in loose stools, watery stools and mucopurulent bloody stools were 3.70% (21/305), 4.23% (3/81) and 0% (0/17) respectively. There was no significant difference between each type of patients (P > 0.05). Results are showed in Table 2.
| Group | n | B.h positive | |
| n | rate | ||
| Normal | 300 | 2 | 0.67 |
| Diarrhea | 403 | 24 | 5.96 |
| Loose stool | 305 | 21 | 3.70 |
| Watery stool | 81 | 3 | 4.23 |
| Mucopurulent bloody stool | 17 | 0 | 0.00 |
Compared with the negative group, the level of CD3+, CD4+ and CD4+/CD8+ of Blastocystis hominis-infected individuals decreased, but that of CD8+ did not change.
Results from this study showed that Blastocystis hominis as an intestinal pathogen in humans was found in Huainan area by stool examination, and the prevalence was not related to gender and living circumstances, and that statistically significant association was observed between the presence of diarrhea and infection with Blastocystis hominis.
In this study, Blastocystis hominis was found in 26 (3.70%) of the 703 stool specimens examined. The positive rates of male was similar to that of female, and there is no significant difference in the positive rates between the diarrhea patients living in urban areas and those in rural areas (P > 0.05), which showed the prevalence of the organism was not related to gender and living environment of the individuals examined.
The results of this study supported the idea that Blastocystis hominis was associated with diarrhea. The positive rates of Blastocystis hominis in stools of the healthy people was 0.67% (2/300), while that of the diarrheic patients was 5.96% (24/403), and the difference between them was significant (P < 0.05). To be exact, the positive rates of Blastocystis hominis was high in stools of the patients with mild diarrhea, intermediate diarrhea and obstinate diarrhea, but there was no Blastocystis hominis found in stools of patients with severe diarrhea. In accordance with other reports[46-49], vacuolar Blastocystis hominis were found in stools of patients with diarrhea with iodine solution and hematoxylin staining. This finding suggested that vacuolar Blastocystis hominis might be the main type of Blastocystis hominis causing diarrhea. Although the reasons why the organism had been found in both symptomatic and asymptomatic individuals have been largely unknown[50-56], one possibility was that it was due to infection time, infection dose, poly-infection with bacteria and the ability of host immunity that might decide whether the symptom turned up or not, because only over 24 h could the cysts of Blastocystis hominis develop into a large number of vacuolar forms[57-58].
In addition, this experiment demonstrated that the hematoxylin staining offered a very convenient and easy method to differentiate the various stages of Blastocystis hominis. As a matter of fact, there is high affinity between hematoxylin and Blastocystis hominis. By hematoxylin staining, the walls, nucleus, chromatoid bodies and other structures of Blastocystis hominis can be observed clearly, and vacuolar, granular, metamorphotic Blastocystis hominis can be easily differentiated from small amebae which do not cause any disease[59-61].
Our study provided evidence for the changes of cellular immune function in Blastocystis hominis-infected individuals. In this paper, the level of CD3+, CD4+, and CD4+/CD8+ decreased in Blastocystis hominis-infected individuals, but that of CD8+ was normal. Compared with the Blastocystis hominis negative group, the difference was significant (P < 0.05). Recent advances in Blastocystis hominis found that in subjects suffering from immunodepression Blastocystis hominis showed a significant association with gastrointestinal symptoms[62-71]. All of these showed that the infection of Blastocystis hominis was related to the hosts’ cellular immune function.
The level of CD4+/CD8+ is key to immunoregulation. When decreased, it suggested that T helper lymphocytes took part in the course of diarrhea caused by Blastocystis hominis. Indeed, both the ability of humoral immunity and that of cellular immunity decreased in the patients with low level of CD4+/CD8+, which made it difficult to cure diarrhea[72-75]. Because of low ability of immunological kill mediated by CD8+ cell, the cellular immunity of human bodies played an important role in the course of diarrhea.
In conclusion, Blastocystis hominis should be kept in mind of parasitologists and physicians when dealing with patients with diarrhea. Blastocystis hominis has long been described as a non-pathogenic protozoan parasite until recently, when claims have been made that it can result in pathogenic conditions[76-78]. Many labs do not know that it is now considered harmful to human bodies, or do not know how to test for it. Moreover, because of absence of specific symptoms, the disease was easily confused with other intestinal diseases and was easily misdiagnosed. The authors suggested that stool examination should be carried out on patients with diarrhea in order to decide whether or not the patients were infected by Blastocystis hominis, and the stool samples should be collected more than once from patients showing clinical signs and symptoms.
We thank Associate Professors Zhu Yu-Xia, Xu Li-Fa, Tang Xiao-Long, Cai Ru, Qian Zhong-Qing, Yang Qing-Gui, He Ji, Zhang Xiu-Yun, Zhou Hui-Sheng, Lu Jun (Department of Etiology and Immunology, School of Medicine, Anhui University of Science & Technology) and some students of our college for their help in sample collection and experimental studies.
Edited by Zhang JZ
| 1. | Rajah Salim H, Suresh Kumar G, Vellayan S, Mak JW, Khairul Anuar A, Init I, Vennila GD, Saminathan R, Ramakrishnan K. Blastocystis in animal handlers. Parasitol Res. 1999;85:1032-1033. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 3.1] [Reference Citation Analysis (0)] |
| 2. | Zaman V, Howe J, Ng M, Goh TK. Scanning electron microscopy of the surface coat of Blastocystis hominis. Parasitol Res. 1999;85:974-976. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
| 3. | Yoshikawa H, Abe N, Iwasawa M, Kitano S, Nagano I, Wu Z, Takahashi Y. Genomic analysis of Blastocystis hominis strains isolated from two long-term health care facilities. J Clin Microbiol. 2000;38:1324-1330. [PubMed] [Cited in This Article: ] |
| 4. | Cheng YQ, Nie QH. Treatment of infectious diarrhea with microecosystem. Shijie Huaren Xiaohua Zazhi. 2001;9:932-934. [Cited in This Article: ] |
| 5. | Dagci H, Ustun S, Taner MS, Ersoz G, Karacasu F, Budak S. Protozoon infections and intestinal permeability. Acta Trop. 2002;81:1-5. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis (0)] |
| 6. | Bhattacharya SK. Therapeutic methods for diarrhea in children. World J Gastroenterol. 2000;6:497-500. [PubMed] [Cited in This Article: ] |
| 7. | He ST, He FZ, Wu CR, Li SX, Liu WX, Yang YF, Jiang SS, He G. Treatment of rotaviral gastroenteritis with Qiwei Baizhu powder. World J Gastroenterol. 2001;7:735-740. [PubMed] [Cited in This Article: ] |
| 8. | Ho LC, Armiugam A, Jeyaseelan K, Yap EH, Singh M. Blastocystis elongation factor-1alpha: genomic organization, taxonomy and phylogenetic relationships. Parasitology. 2000;121:135-144. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
| 9. | Nasirudeen AM, Singh M, Yap EH, Tan KS. Blastocystis hominis: evidence for caspase-3-like activity in cells undergoing programmed cell death. Parasitol Res. 2001;87:559-565. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 10. | Iqbal J, Hira PR, Al-Ali F, Philip R. Cryptosporidiosis in Kuwaiti children: seasonality and endemicity. Clin Microbiol Infect. 2001;7:261-266. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis (0)] |
| 11. | Cao YL. Laboratory diagnosis of infectious diarrhea. Shijie Huaren Xiaohua Zazhi. 2001;9:927-928. [Cited in This Article: ] |
| 12. | Windsor JJ, Macfarlane L, Whiteside TM, Chalmers RM, Thomas AL, Joynson DH. Blastocystis hominis: a common yet neglected human parasite. Br J Biomed Sci. 2001;58:129-130. [PubMed] [Cited in This Article: ] |
| 13. | Force M, Sparks WS, Ronzio RA. Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytother Res. 2000;14:213-214. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 2] [Reference Citation Analysis (0)] |
| 14. | Katz DE, Taylor DN. Parasitic infections of the gastrointestinal tract. Gastroenterol Clin North Am. 2001;30:797-815, x. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
| 15. | Taamasri P, Mungthin M, Rangsin R, Tongupprakarn B, Areekul W, Leelayoova S. Transmission of intestinal blastocystosis related to the quality of drinking water. Southeast Asian J Trop Med Public Health. 2000;31:112-117. [PubMed] [Cited in This Article: ] |
| 16. | Xia B, Shivananda S, Zhang GS, Yi JY, Crusius JBA, Peka AS. Inflammatory bowel disease in Hubei Province of China. China Natl J New Gastroenterol. 1998;3:119-120. [Cited in This Article: ] |
| 17. | Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis. 1999;18:436-439. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 2.9] [Reference Citation Analysis (0)] |
| 18. | Zhou JL, Xu CH. The method of treatment on protozoon diarrhea. Huaren Xiaohua Zazhi. 2000;8:93-95. [Cited in This Article: ] |
| 19. | Zhou X, Li N, Li JS. Growth hormone stimulates remnant small bowel epithelial cell proliferation. World J Gastroenterol. 2000;6:909-913. [PubMed] [Cited in This Article: ] |
| 20. | Barrett KE. New insights into the pathogenesis of intestinal dysfunction: secretory diarrhea and cystic fibrosis. World J Gastroenterol. 2000;6:470-474. [PubMed] [Cited in This Article: ] |
| 21. | Tan KS, Singh M, Yap EH. Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasitol. 2002;32:789-804. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 4.1] [Reference Citation Analysis (0)] |
| 22. | Fan WG, Long YH. Diarrhea in travelers. Shijie Huaren Xiaohua Zazhi. 2000;8:937-938. [Cited in This Article: ] |
| 23. | Arisue N, Hashimoto T, Yoshikawa H, Nakamura Y, Nakamura G, Nakamura F, Yano TA, Hasegawa M. Phylogenetic position of Blastocystis hominis and of stramenopiles inferred from multiple molecular sequence data. J Eukaryot Microbiol. 2002;49:42-53. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 3.5] [Reference Citation Analysis (0)] |
| 24. | Tan KS, Ng GC, Quek E, Howe J, Ramachandran NP, Yap EH, Singh M. Blastocystis hominis: A simplified, high-efficiency method for clonal growth on solid agar. Exp Parasitol. 2000;96:9-15. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
| 25. | Feng ZH. Application of gene vaccine and vegetable gene in infective diarrhea. Shijie Huaren Xiaohua Zazhi. 2000;8:934-936. [Cited in This Article: ] |
| 26. | Chen XQ, Singh M, Ho LC, Tan SW, Yap EH. Characterization of protein profiles and cross-reactivity of Blastocystis antigens by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analysis. Parasitol Res. 1999;85:343-346. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 27. | Scrimgeour D. Chronic intermittent diarrhoea and fatigue. Aust Fam Physician. 2001;30:897. [PubMed] [Cited in This Article: ] |
| 28. | Zaman V, Howe J, Ng M. Scanning electron microscopy of Blastocystis hominis cysts. Parasitol Res. 1998;84:476-477. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 29. | Xiao YH. Treatment of infective Diarrhea with antibiotic. Shijie Huaren Xiaohua Zazhi. 2000;8:930-932. [Cited in This Article: ] |
| 30. | Moe KT, Singh M, Gopalakrishnakone P, Ho LC, Tan SW, Chen XQ, Yap EH. Cytopathic effect of Blastocystis hominis after intramuscular inoculation into laboratory mice. Parasitol Res. 1998;84:450-454. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
| 31. | Ok UZ, Girginkardeşler N, Balcioğlu C, Ertan P, Pirildar T, Kilimcioğlu AA. Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol. 1999;94:3245-3247. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.1] [Reference Citation Analysis (0)] |
| 32. | Fryauff DJ, Prodjodipuro P, Basri H, Jones TR, Mouzin E, Widjaja H, Subianto B. Intestinal parasite infections after extended use of chloroquine or primaquine for malaria prevention. J Parasitol. 1998;84:626-629. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 33. | Horiki N, Kaneda Y, Maruyama M, Fujita Y, Tachibana H. Intestinal blockage by carcinoma and Blastocystis hominis infection. Am J Trop Med Hyg. 1999;60:400-402. [PubMed] [Cited in This Article: ] |
| 34. | Lanuza MD, Carbajal JA, Villar J, Mir A, Borrás R. Soluble-protein and antigenic heterogeneity in axenic Blastocystis hominis isolates: pathogenic implications. Parasitol Res. 1999;85:93-97. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 35. | Haresh K, Suresh K, Khairul Anus A, Saminathan S. Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health. 1999;4:274-277. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.2] [Reference Citation Analysis (0)] |
| 36. | Hoevers J, Holman P, Logan K, Hommel M, Ashford R, Snowden K. Restriction-fragment-length polymorphism analysis of small-subunit rRNA genes of Blastocystis hominis isolates from geographically diverse human hosts. Parasitol Res. 2000;86:57-61. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
| 37. | Lee JD, Wang JJ, Chung LY, Chang EE, Lai LC, Chen ER, Yen CM. A survey on the intestinal parasites of the school children in Kaohsiung county. Kaohsiung J Med Sci. 2000;16:452-458. [PubMed] [Cited in This Article: ] |
| 38. | Romero Cabello R, Guerrero LR, Muñóz García MR, Geyne Cruz A. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg. 1997;91:701-703. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 100] [Cited by in F6Publishing: 100] [Article Influence: 3.7] [Reference Citation Analysis (0)] |
| 39. | Yoshikawa H, Nagano I, Wu Z, Yap EH, Singh M, Takahashi Y. Genomic polymorphism among Blastocystis hominis strains and development of subtype-specific diagnostic primers. Mol Cell Probes. 1998;12:153-159. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 3.0] [Reference Citation Analysis (0)] |
| 40. | Barret JP, Dardano AN, Heggers JP, McCauley RL. Infestations and chronic infections in foreign pediatric patients with burns: is there a role for specific protocols? J Burn Care Rehabil. 1999;20:482-486. [PubMed] [Cited in This Article: ] |
| 41. | Kaneda Y, Horiki N, Cheng XJ, Fujita Y, Maruyama M, Tachibana H. Ribodemes of Blastocystis hominis isolated in Japan. Am J Trop Med Hyg. 2001;65:393-396. [PubMed] [Cited in This Article: ] |
| 42. | Taşova Y, Sahin B, Koltaş S, Paydaş S. Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama. 2000;54:133-136. [PubMed] [Cited in This Article: ] |
| 43. | Jensen B, Kepley W, Guarner J, Anderson K, Anderson D, Clairmont J, De L'aune W, Austin EH, Austin GE. Comparison of polyvinyl alcohol fixative with three less hazardous fixatives for detection and identification of intestinal parasites. J Clin Microbiol. 2000;38:1592-1598. [PubMed] [Cited in This Article: ] |
| 44. | Herwaldt BL, de Arroyave KR, Wahlquist SP, de Merida AM, Lopez AS, Juranek DD. Multiyear prospective study of intestinal parasitism in a cohort of Peace Corps volunteers in Guatemala. J Clin Microbiol. 2001;39:34-42. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis (0)] |
| 45. | Guignard S, Arienti H, Freyre L, Lujan H, Rubinstein H. Prevalence of enteroparasites in a residence for children in the Córdoba Province, Argentina. Eur J Epidemiol. 2000;16:287-293. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
| 46. | Garcia LS, Shimizu RY. Evaluation of intestinal protozoan morphology in human fecal specimens preserved in EcoFix: comparison of Wheatley's trichrome stain and EcoStain. J Clin Microbiol. 1998;36:1974-1976. [PubMed] [Cited in This Article: ] |
| 47. | Tan KS, Howe J, Yap EH, Singh M. Do Blastocystis hominis colony forms undergo programmed cell death? Parasitol Res. 2001;87:362-367. [PubMed] [Cited in This Article: ] |
| 48. | Abou El Naga IF, Negm AY. Morphology, histochemistry and infectivity of Blastocystis hominis cyst. J Egypt Soc Parasitol. 2001;31:627-635. [PubMed] [Cited in This Article: ] |
| 49. | Vdovenko AA. Blastocystis hominis: origin and significance of vacuolar and granular forms. Parasitol Res. 2000;86:8-10. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 50. | Brandonisio O, Maggi P, Panaro MA, Lisi S, Andriola A, Acquafredda A, Angarano G. Intestinal protozoa in HIV-infected patients in Apulia, South Italy. Epidemiol Infect. 1999;123:457-462. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
| 51. | Amin AM. Blastocystis hominis among apparently healthy food handlers in Jeddah, Saudi Arabia. J Egypt Soc Parasitol. 1997;27:817-823. [PubMed] [Cited in This Article: ] |
| 52. | Vennila GD, Suresh Kumar G, Khairul Anuar A, Rajah S, Saminathan R, Sivanandan S, Ramakrishnan K. Irregular shedding of Blastocystis hominis. Parasitol Res. 1999;85:162-164. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
| 53. | Hellard ME, Sinclair MI, Hogg GG, Fairley CK. Prevalence of enteric pathogens among community based asymptomatic individuals. J Gastroenterol Hepatol. 2000;15:290-293. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 3.2] [Reference Citation Analysis (0)] |
| 54. | Walderich B, Bernauer S, Renner M, Knobloch J, Burchard GD. Cytopathic effects of Blastocystis hominis on Chinese hamster ovary (CHO) and adeno carcinoma HT29 cell cultures. Trop Med Int Health. 1998;3:385-390. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
| 55. | Svenungsson B, Lagergren A, Ekwall E, Evengård B, Hedlund KO, Kärnell A, Löfdahl S, Svensson L, Weintraub A. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis. 2000;30:770-778. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 154] [Cited by in F6Publishing: 144] [Article Influence: 6.0] [Reference Citation Analysis (0)] |
| 56. | Gericke AS, Burchard GD, Knobloch J, Walderich B. Isoenzyme patterns of Blastocystis hominis patient isolates derived from symptomatic and healthy carriers. Trop Med Int Health. 1997;2:245-253. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
| 57. | Zaman V, Zaki M, Manzoor M, Howe J, Ng M. Postcystic development of Blastocystis hominis. Parasitol Res. 1999;85:437-440. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
| 58. | Moe KT, Singh M, Howe J, Ho LC, Tan SW, Chen XQ, Yap EH. Development of Blastocystis hominis cysts into vacuolar forms in vitro. Parasitol Res. 1999;85:103-108. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
| 59. | Vdovenko AA, Williams JE. Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing. Parasitol Res. 2000;86:573-581. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
| 60. | Zaman V. The differential identification of Blastocystis hominis cysts. Ann Trop Med Parasitol. 1998;92:233-235. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 61. | Leber AL. Intestinal amebae. Clin Lab Med. 1999;19:601-19, vii. [PubMed] [Cited in This Article: ] |
| 62. | Amenta M, Dalle Nogare ER, Colomba C, Prestileo TS, Di Lorenzo F, Fundaro S, Colomba A, Ferrieri A. Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections. J Chemother. 1999;11:391-395. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
| 63. | Wilcox CM. Etiology and evaluation of diarrhea in AIDS: a global perspective at the millennium. World J Gastroenterol. 2000;6:177-186. [PubMed] [Cited in This Article: ] |
| 64. | Lebbad M, Norrgren H, Nauclér A, Dias F, Andersson S, Linder E. Intestinal parasites in HIV-2 associated AIDS cases with chronic diarrhoea in Guinea-Bissau. Acta Trop. 2001;80:45-49. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
| 65. | Menon BS, Abdullah MS, Mahamud F, Singh B. Intestinal parasites in Malaysian children with cancer. J Trop Pediatr. 1999;45:241-242. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
| 66. | Germani Y, Minssart P, Vohito M, Yassibanda S, Glaziou P, Hocquet D, Berthélémy P, Morvan J. Etiologies of acute, persistent, and dysenteric diarrheas in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Am J Trop Med Hyg. 1998;59:1008-1014. [PubMed] [Cited in This Article: ] |
| 67. | Ghosh K, Ayyaril M, Nirmala V. Acute GVHD involving the gastrointestinal tract and infestation with Blastocystis hominis in a patient with chronic myeloid leukaemia following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998;22:1115-1117. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
| 68. | Cimerman S, Cimerman B, Lewi DS. Prevalence of intestinal parasitic infections in patients with acquired immunodeficiency syndrome in Brazil. Int J Infect Dis. 1999;3:203-206. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 2.3] [Reference Citation Analysis (0)] |
| 69. | Li MD. Diarrhea in AIDS. Shijie Huaren Xiaohua Zazhi. 2000;8:937-938. [Cited in This Article: ] |
| 70. | Prasad KN, Nag VL, Dhole TN, Ayyagari A. Identification of enteric pathogens in HIV-positive patients with diarrhoea in northern India. J Health Popul Nutr. 2000;18:23-26. [PubMed] [Cited in This Article: ] |
| 71. | Mathewson JJ, Salameh BM, DuPont HL, Jiang ZD, Nelson AC, Arduino R, Smith MA, Masozera N. HEp-2 cell-adherent Escherichia coli and intestinal secretory immune response to human immunodeficiency virus (HIV) in outpatients with HIV-associated diarrhea. Clin Diagn Lab Immunol. 1998;5:87-90. [PubMed] [Cited in This Article: ] |
| 72. | Kaneda Y, Horiki N, Cheng X, Tachibana H, Tsutsumi Y. Serologic response to Blastocystis hominis infection in asymptomatic individuals. Tokai J Exp Clin Med. 2000;25:51-56. [PubMed] [Cited in This Article: ] |
| 73. | Nasirudeen AM, Tan KS, Singh M, Yap EH. Programmed cell death in a human intestinal parasite, Blastocystis hominis. Parasitology. 2001;123:235-246. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis (0)] |
| 74. | Long HY, Handschack A, König W, Ambrosch A. Blastocystis hominis modulates immune responses and cytokine release in colonic epithelial cells. Parasitol Res. 2001;87:1029-1030. [PubMed] [Cited in This Article: ] |
| 75. | Tan KS, Ibrahim M, Ng GC, Nasirudeen AM, Ho LC, Yap EH, Singh M. Exposure of Blastocystis species to a cytotoxic monoclonal antibody. Parasitol Res. 2001;87:534-538. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
| 76. | Cirioni O, Giacometti A, Drenaggi D, Ancarani F, Scalise G. Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts. Eur J Epidemiol. 1999;15:389-393. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 2.7] [Reference Citation Analysis (1)] |
| 77. | Waring L, Reed C. Blastocystis hominis. Causative organism or harmless commensal? Aust Fam Physician. 2001;30:374; quiz 378. [PubMed] [Cited in This Article: ] |
| 78. | Koutsavlis AT, Valiquette L, Allard R, Soto J. Blastocystis hominis: a new pathogen in day-care centres? Can Commun Dis Rep. 2001;27:76-84. [PubMed] [Cited in This Article: ] |